Intrathecal Chemotherapy: Uses, Procedure, Side Effects

Intrathecal chemotherapy delivers cancer drugs directly into the cerebrospinal fluid (CSF). This fluid surrounds the brain and spinal cord, so the drug spreads throughout this entire space. As a result, doctors can treat cancer cells that have spread into the CSF, a condition many intravenous drugs cannot reach effectively.

What Is Intrathecal Chemotherapy?

Intrathecal chemotherapy means injecting a drug directly into the CSF, rather than into a vein. Doctors deliver the drug through a lumbar puncture, or through a catheter connected to an Ommaya reservoir. Either way, the drug distributes throughout the CSF, bathing the brain and spinal cord.

This approach differs from intracavitary chemotherapy, which targets one specific tumor cavity or cyst instead. Our comparison guide explains this key difference in more detail.

Feature	Detail
Delivery site	Cerebrospinal fluid, via lumbar puncture or reservoir
Main goal	Treat cancer cells spread through the CSF
Common conditions treated	Leptomeningeal disease, certain leukemias and lymphomas
Typical frequency	Scheduled sessions over weeks to months

Why Doctors Use Intrathecal Chemotherapy

The blood brain barrier blocks many drugs from reaching the CSF through the bloodstream. Therefore, doctors bypass this barrier by injecting the drug directly where it needs to work. This matters greatly for cancers that spread along the brain and spinal cord lining.

• Leptomeningeal metastasis from breast, lung, or other cancers
• Certain leukemias and lymphomas that can spread to the CSF
• Prevention of CSF spread in high risk blood cancers
• Some primary brain tumors with CSF involvement

How Doctors Deliver Intrathecal Chemotherapy

Doctors use two main delivery routes for this treatment. A lumbar puncture involves a needle inserted into the lower spine for each session. Alternatively, a catheter connected to an Ommaya reservoir allows repeated access without a new spinal needle each time.

Delivery Route	Best Suited For
Lumbar puncture	Short courses or occasional treatment
Ommaya reservoir	Frequent, ongoing treatment over weeks or months

Our guide to Ommaya reservoir placement surgery explains how surgeons place this device when needed.

What Happens During Treatment

During a lumbar puncture, the patient lies on their side while the doctor inserts a needle into the lower back. The doctor then injects the chemotherapy drug slowly into the CSF. The entire procedure typically takes fifteen to thirty minutes.

During reservoir based treatment, a clinician accesses the dome with a small needle instead. The clinician may withdraw fluid first, then inject the drug. So each reservoir session is generally quicker and more comfortable than a fresh lumbar puncture.

Common Drugs Used in Intrathecal Chemotherapy

Doctors select specific drugs approved for intrathecal use, since not all chemotherapy drugs are safe to inject into the CSF. Methotrexate and cytarabine are among the most commonly used agents for this purpose. Additionally, doctors sometimes combine these drugs with a steroid to reduce irritation.

The specific drug and dose depend on the cancer type. Therefore, an oncologist tailors the regimen to each patient’s diagnosis and treatment history.

Side Effects of Intrathecal Chemotherapy

Most patients tolerate intrathecal chemotherapy reasonably well. However, some experience headache, nausea, or temporary neck stiffness after treatment. These symptoms usually result from mild irritation of the CSF lining, called chemical meningitis.

• Headache, often the most common side effect
• Nausea or vomiting after treatment
• Temporary neck stiffness or mild fever
• Rarely, more serious neurological symptoms requiring urgent evaluation

Doctors monitor patients closely after each session to catch any complication early. For device related risks, see our guide to Ommaya reservoir risks and complications.

How Often Is Treatment Needed?

Treatment schedules vary widely based on diagnosis and treatment goals. Some patients receive intrathecal chemotherapy weekly during an initial intensive phase. Afterward, many transition to a less frequent maintenance schedule.

Your oncologist will design a schedule specific to your cancer type and response to treatment. Therefore, no single schedule applies to every patient equally.

Intrathecal Chemotherapy vs Other Treatment Options

Intrathecal chemotherapy is not the only way to treat CSF involvement. Radiation to the brain and spine offers another option, particularly for widespread disease. In some cases, doctors combine both approaches for a more complete treatment strategy.

Our overview of treatment approaches for brain tumors explains how these methods fit together. In addition, our article on intracavitary chemotherapy covers a related but distinct local treatment option.

Monitoring Response to Treatment

Doctors monitor treatment response through repeated CSF sampling and imaging. For example, cytology tests check the CSF for remaining cancer cells over time. Consequently, the care team adjusts the treatment plan based on these results.

Monitoring Method	Purpose
CSF cytology	Checks for cancer cells in the fluid
Brain and spine MRI	Tracks disease extent over time
Neurological exams	Detects new or worsening symptoms

Questions to Ask Your Oncologist

• Why does my diagnosis call for intrathecal chemotherapy?
• Will I need a reservoir, or will lumbar punctures suffice?
• What side effects should I expect after each session?
• How will you measure whether the treatment is working?

A History of Intrathecal Chemotherapy

Doctors first developed intrathecal chemotherapy decades ago to treat childhood leukemia spreading to the CSF. Since then, this approach has replaced cranial radiation for many pediatric patients, reducing long term side effects. Consequently, intrathecal chemotherapy became a standard part of leukemia and lymphoma protocols worldwide.

Over time, doctors extended this technique to treat leptomeningeal spread from solid tumors as well. Today, oncologists use it across a range of cancers whenever CSF involvement occurs.

Preparing for Your First Treatment Session

Before starting treatment, doctors review recent imaging and blood work carefully. In addition, they discuss whether a reservoir makes sense for your expected treatment length. Patients should ask about pre-medication, since some centers give anti-nausea medication beforehand.

Patients should also arrange a ride home after each session, especially early in treatment. Therefore, planning ahead helps make the whole process smoother and less stressful.

Managing Side Effects Between Sessions

Simple steps can ease common side effects like headache and mild nausea. For example, resting flat for a short time after lumbar puncture based treatment often reduces headache severity. In addition, staying well hydrated supports faster recovery between sessions.

• Rest quietly for a period after each session, as advised by your team.
• Stay hydrated in the hours following treatment.
• Take prescribed anti-nausea medication if symptoms develop.
• Report any severe or worsening symptoms right away.

The Role of the Care Team

Intrathecal chemotherapy involves close coordination between neurosurgery, oncology, and nursing staff. The neurosurgeon may place and manage the reservoir, when one is used. Meanwhile, the oncologist determines the drug, dose, and schedule based on the specific diagnosis.

Nursing staff perform many routine reservoir taps and monitor patients during each visit. Therefore, this coordinated team approach helps ensure both safety and consistency throughout treatment.

Traveling for Treatment as an International Patient

Many international patients coordinate intrathecal chemotherapy alongside neurosurgical care in Istanbul. Therefore, treatment planning often considers travel schedules and the total length of stay required. Patients receiving an Ommaya reservoir typically plan for both the surgery and the following treatment sessions.

Our contact page can help coordinate this planning with your home country’s oncology team as well.

Risks Specific to the Delivery Method

Lumbar puncture based treatment carries its own set of risks, separate from the drug itself. For example, repeated spinal needles can cause cumulative discomfort and, rarely, a persistent CSF leak. In contrast, reservoir based treatment shifts most of the procedural risk to the initial surgery.

Therefore, patients needing many sessions often find reservoir based delivery more comfortable overall. Our guide to the Ommaya reservoir explains this device and its own risk profile in detail.

Nutritional and Physical Wellness During Treatment

Good nutrition supports the body through any cancer treatment, including intrathecal chemotherapy. For example, adequate protein intake helps maintain strength and supports healing after each session. In addition, gentle physical activity, when approved by your doctor, can help manage fatigue.

Therefore, patients should discuss nutrition and activity goals with their care team throughout treatment. This proactive approach often improves how patients feel during a demanding treatment course.

What Determines Treatment Success?

Several factors influence how well intrathecal chemotherapy controls disease in the CSF. For instance, the extent of disease at the start of treatment matters significantly. In addition, how consistently a patient completes the planned treatment schedule affects outcomes.

Therefore, doctors emphasize completing the full recommended course whenever possible. Missing sessions can reduce the treatment’s overall effectiveness against CSF disease.

Combining Intrathecal Chemotherapy With Other Treatments

Doctors often combine intrathecal chemotherapy with systemic therapy or radiation for a more complete approach. For example, a patient might receive systemic chemotherapy for the primary tumor while also receiving intrathecal treatment for CSF involvement. Consequently, this combined strategy addresses disease in multiple locations at once.

Some patients also explore newer combined approaches involving immunotherapy. Our page on immunotherapy for brain tumors discusses these emerging strategies further.

What the Research Shows About Effectiveness

Decades of clinical research support intrathecal chemotherapy for specific cancers spreading to the CSF. For example, this approach has significantly improved outcomes in childhood leukemia when combined with systemic treatment. However, effectiveness varies by cancer type, extent of spread, and how early treatment begins.

Therefore, doctors set realistic, individualized goals for each patient rather than promising a single expected outcome. Ongoing research continues to refine drug choices and treatment schedules for better results.

Consequently, patients today benefit from a much larger body of evidence than patients treated decades ago. So current treatment protocols reflect this accumulated clinical experience.

Emotional and Practical Support During Treatment

A cancer diagnosis involving the CSF can feel overwhelming for patients and families alike. Therefore, many centers offer counseling and support resources alongside medical treatment. In addition, connecting with other patients who have undergone similar treatment can ease anxiety.

Practical support, such as help with transportation and daily tasks, also makes a meaningful difference. So we encourage patients to build a support network before starting treatment, not only during difficult moments.

In addition, many patients find that keeping a simple symptom diary helps them communicate clearly with their care team. Therefore, we recommend noting any new symptoms, however minor they seem, between visits.

Choosing an Experienced Care Team

Experience matters greatly for both reservoir placement and ongoing intrathecal treatment. For instance, an experienced team recognizes early warning signs of complications more reliably. In addition, consistent nursing staff build familiarity with each patient’s specific needs over time.

Prof. Dr. Serdar Baki Albayrak’s team coordinates closely with oncology colleagues to manage this treatment safely. Therefore, patients benefit from a well established, multidisciplinary approach throughout their care.

Frequently Asked Questions

What conditions does intrathecal chemotherapy treat?

Doctors use it mainly for leptomeningeal disease and certain leukemias or lymphomas that spread to the CSF.

Is intrathecal chemotherapy painful?

Most patients feel only brief discomfort during needle insertion. Headache afterward is common but usually manageable with rest and medication.

How is this different from intracavitary chemotherapy?

Intrathecal chemotherapy spreads through the entire CSF space. Intracavitary chemotherapy instead targets one specific tumor cavity. Our comparison article explains this fully.

Can children receive intrathecal chemotherapy?

Yes. In fact, doctors have used this treatment safely in pediatric leukemia care for decades.

Does intrathecal chemotherapy cause hair loss?

Generally, no. Because the drug stays within the CSF, it typically does not cause the systemic side effects associated with intravenous chemotherapy.

How long does each treatment session take?

A single session usually takes fifteen to thirty minutes, plus a short observation period afterward.

Will I need imaging before every treatment session?

Not usually. Doctors typically order imaging periodically, rather than before every single session, to track overall treatment response.

Can intrathecal chemotherapy be stopped if side effects are severe?

Yes. Doctors adjust or pause treatment when side effects become significant. Open communication with your care team makes this adjustment possible.

Does this treatment require hospital admission?

Most sessions happen on an outpatient basis. However, patients receiving a new reservoir will need a brief hospital stay for the placement surgery itself.

What should I eat or avoid before treatment?

Generally, patients can eat normally before a lumbar puncture based session. However, your care team will give specific fasting instructions if you are also receiving anesthesia for reservoir surgery.

For more on how this fits within a broader treatment plan, visit our page on glioblastoma. To discuss your treatment options, please contact our team directly.

Reviewed by Prof. Dr. Serdar Baki Albayrak, Neurosurgeon, Istanbul, Turkey.

Medical disclaimer: This article is for general informational purposes only. It does not replace professional medical diagnosis or treatment. Please consult Prof. Dr. Serdar Baki Albayrak or another qualified physician directly to discuss your individual case.